Clinical trial
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00109876
Study timeline
Study start (unknown)2006-09-01Date precision: month
Registry last updated2017-03-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
BostonMassachusetts, United States2SpokaneWashington, United States2Los AngelesCalifornia, United States1DallasTexas, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1PortlandOregon, United States1Salt Lake CityUtah, United States1Chapel HillNorth Carolina, United States1SacramentoCalifornia, United States1MilwaukeeWisconsin, United States1ProvidenceRhode Island, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00109876 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.